xCures Raises $46 Million Series B to Expand Clinical Clarity Platform

June 25, 2026
xCures has raised $46 million in Series B funding led by Innovius Capital. The financing will support the expansion of its platform that converts fragmented medical records into structured clinical data.

xCures has closed a $46 million Series B financing round led by Innovius Capital, with participation from iGrow, GKCC, Spring Mountain Capital, and existing investors, announced in a press release. The new funding brings the company's total capital raised to more than $76 million.

The investment will be used to expand xCures' Clinical Clarity Engine, which transforms fragmented medical records into structured, decision ready clinical data. The company has processed over 300 million medical records from more than 550,000 healthcare locations across the United States, supporting clinical decision making for millions of patients.

xCures CEO Mika Newton said the funding will accelerate product development, expand the team, and help more organizations convert unstructured records into actionable information.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

06/25
ARCYN Defense Opens Second Seed Round to Advance Iron Rain Counter-UAS System
06/25
Valence AI Raises $5 Million and Secures Patents for Emotional Detection in Speech
06/25
Chicago Pacific Founders Invests in Attune to Improve Healthcare Coordination
06/25
Attention Raises $30 Million Series B for AI Sales Platform
06/25
Trovy Raises $15 Million Series A Led by Left Lane Capital

More from: Life Sciences

06/25
Chicago Pacific Founders Invests in Attune to Improve Healthcare Coordination
06/25
Children’s Hospital of Philadelphia Develops AI Tool to Guide Genetic Testing for Rare Diseases
06/25
Sera Prognostics Joins ARPA-H Program to Develop Point of Care Birth Diagnostic
06/24
Ascletis Pharma Receives FDA Clearance for Phase I Study of ASC35 Obesity Drug
06/24
Redox Adds AI Capabilities to Its Healthcare Data Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like